In the original paper, mistakes occurred in Figures [1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, and [3](#fig3){ref-type="fig"} should be replaced with the figures below. In addition, a new author Fujiang Cao has been added as the second author in this paper.

![IKK*α* protein expression in the cerebellum of autistic subjects. (a) Western blot studies on cerebellar homogenates using IKK*α* antibody (dilution 1 : 1000). Lanes 1--7 represent control subjects and lanes 8--14 represent autistic subjects. (b) The blots shown in (a) were quantitated after being normalized by actin. Data are shown as mean ± SE. \**P* \< 0.05 versus control group.](MI2013-691975.001){#fig1}

![I*κB*α** inhibitory subunit expression in the cerebellum of autistic subjects. Western blot studies on cerebellar homogenates using I*κB*α** antibody (dilution 1 : 1000). Lanes 1--7 represent control subjects and lanes 8--14 represent autistic subjects. The western blot results were quantitated after being normalized by actin. Data are shown as mean ± SE.](MI2013-691975.002){#fig2}

![NF-*κ*B p65 protein expression in the cerebellum of autistic subjects. Western blot studies on cerebellar homogenates using I*κB*α** antibody (dilution 1 : 500). Lanes 1--7 represent control subjects and lanes 8--14 represent autistic subjects. The western blot results were quantitated after being normalized by actin. Data are shown as mean ± SE.](MI2013-691975.003){#fig3}
